NCT03371758Unknown不适用
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo and Healthy Control; Comparative Study
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Expression of LC3-I, LC3-II & Beclin 1 in vitiligo patients
研究概览
简要总结
The exact mechanism of impairment of autophagy in vitiligo has not yet been determined.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •• Patients with non-segmental vitiligo whether active or stable.
- •Age above 12 years.
- •Both sexes.
排除标准
- •• Patients should not use any topical or systemic treatment at least 6 weeks before inclusion into the study.
- •Patients having other autoimmune disease, heart disease, liver disease, kidney disease, neurological disorder, cancer, active infection or any chronic disease.
- •Pregnancy or breast feeding for female patients.
结局指标
主要结局
Expression of LC3-I, LC3-II & Beclin 1 in vitiligo patients
时间窗: 1 year
次要结局
未报告次要终点
研究者
Maha Fathy Elmasry
Principal investigator
Cairo University
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
A Novel Surgical Method in the Treatment of Unstable VitiligoVitiligoNCT03013049Post Graduate Institute of Medical Education and Research, Chandigarh40
已完成
1 期
Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of VitiligoVitiligoNCT01511965Centre Hospitalier Universitaire de Nice23
终止
2 期
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of VitiligoVitiligoNCT02191748Rutgers, The State University of New Jersey22
尚未招募
不适用
Histochemical Study of Vitiligo in Sohag University Hospital PatientsVitiligoNCT05869942Sohag University60
进行中（未招募）
3 期
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With VitiligoNCT06118411AbbVie614